ORAMED PHARMACEUTICALS INC. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Oramed Pharmaceuticals Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q2 2021 to Q2 2024.
  • Oramed Pharmaceuticals Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2024 was $19K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $19K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $19K Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $25K -$25K -50% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $27K -$24K -47.1% Sep 30, 2023 10-Q 2023-11-09
Q4 2022 $50K +$22K +78.6% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 $51K +$19K +59.4% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $59K +$23K +63.9% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $61K Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $28K Dec 31, 2021 10-Q 2022-11-10
Q3 2021 $32K Aug 31, 2021 10-QT 2022-03-30
Q2 2021 $36K May 31, 2021 10-Q 2021-07-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.